tiprankstipranks
ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD

ACADIA Pharmaceuticals (ACAD) Similar Stocks

Compare
2,293 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
ACADIA Pharmaceuticals
$17.19
$2.84B
12.52
-7.03%
9 Buy
6 Hold
0 Sell
Moderate Buy
Neurocrine
$114.00
$11.41B
34.78
-19.24%
17 Buy
5 Hold
0 Sell
Strong Buy
Prothena
$13.01
$680.91M
-47.43%
6 Buy
2 Hold
0 Sell
Strong Buy
Intra-Cellular Therapies
$131.75
$14.03B
95.68%
4 Buy
9 Hold
0 Sell
Moderate Buy
SAGE Therapeutics
$8.66
$528.74M
-53.49%
2 Buy
14 Hold
1 Sell
Hold
Axsome Therapeutics
$121.77
$5.87B
52.59%
17 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ACAD
ACADIA Pharmaceuticals
17.19
-1.30
-7.03%
NBIX
Neurocrine
114.00
-23.92
-17.34%
PRTA
Prothena
13.01
-11.76
-47.48%
ITCI
Intra-Cellular Therapies
131.75
62.55
90.39%
SAGE
SAGE Therapeutics
8.66
-10.08
-53.79%
AXSM
Axsome Therapeutics
121.77
41.97
52.59%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis